In 2021 NCRI Partner Prostate Cancer Research ran a grant call focused on combating racial disparities in prostate cancer. To…
Using lived experience to help people affected by prostate cancer
'Prostate Cancer Research has announced the creation of a new website for people affected by prostate cancer. Prostate Cancer Research…
Blood tests predict which prostate cancer patients are resistant to chemotherapy drug
'Regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or…
Using knowledge provided by NCRI research funding data to increase the impact of prostate cancer research
'Prostate Cancer Research recognised that with a large number of cancer research charities duplication was a possibility and that challenges…
Accurate detection of prostate cancer and the crucial role of patient involvement
'The Prostagram trial investigated the use of MRI scans to detect prostate cancer. At present, there is no nationally approved…
Quick and efficient testing of prostate cancer treatments, changing trial design and clinical practice
'Lack of treatments and evidence As recently as ten years ago, despite many new drugs being approved for use in…
Reducing the number of prostate biopsies by improving diagnosis
'Addressing problems with prostate cancer diagnosis To diagnose prostate cancer, PSA (prostate specific antigen) levels in the blood are used…
Reducing the prostate cancer treatment burden on both patients and the health service
'Radiotherapy treatment for prostate cancer Standard radiotherapy for prostate cancer is an important and effective treatment, but until recently involved…
High levels of two hormones in the blood raise prostate cancer risk
'Men with higher levels of ‘free’ testosterone and a growth hormone in their blood are more likely to be diagnosed…
Men with prostate cancer are willing to accept lower survival odds to side effects
'Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival…
Low testosterone levels linked to reduced risk of prostate cancer
'Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer, according…
Marker for aggressive prostate cancer doubles-up as a drug target
'Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to…